Press Releases

May 05, 2003 HEMISPHERX BIOPHARMA ENTERS INTO THERAPEUTIC AGREEMENT FOR AMPLIGEN® WITH THE CENTER FOR CELL AND GENE THERAPY AT BAYLOR COLLEGE OF MEDICINE

Apr 29, 2003 HEMISPHERX REPORTS EXPANDED HIV DATA ON AMPLIGEN AT THE 16th INTERNATIONAL CONFERENCE ON ANTIVIRAL RESEARCH

Apr 22, 2003 HEMISPHERX BIOPHARMA EXTENDS DISTRIBUTOR AGREEMENT FOR ALFERON N Injection

Apr 15, 2003 Hemispherx Biopharma Announces Fourth Quarter and Year 2002 Results

Apr 08, 2003 Webcast Alert: Hemispherx BioPharma, Inc. Announces HEB Presentation at Redchip Partners New York Investor Conference 2003 Webcast

Mar 26, 2003 HEMISPHERX BIOPHARMA APPOINTS DAVID FEDORCZYK DIRECTOR OF CLINICAL AND STATISTICAL AFFAIRS

Mar 24, 2003 HEMISPHERX BIOPHARMA APPOINTS DR. JAMES KNILL VICE PRESIDENT OF CLINICAL DEVELOPMENT OF THE HIV/AIDS DIVISION

Mar 20, 2003 HEMISPHERX BIOPHARMA TO PRESENT AT THE STRATEGIC RESEARHC INTSTITUTES FIRST 'siRNA' CONFERENCE

Mar 18, 2003 REBROADCAST OF HEMISPHERX'S MARCH 18, 2003 CONFERENCE CALL AVAILABLE ON COMPANY'S WEBSITE OR VIA TELEPHONE REPLAY

Mar 13, 2003 HEMISPHERX TO HOST CONFERENCE CALL ON TUESDAY, MARCH 18, 2003 AT 11:00AM EST

62 63 64 65 66 67 68 69 70 71 72

<< < > >>